Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Revisiting the standards of cancer detection and therapy alongside their comparison to modern methods
Piotr Gromek, Zuzanna Senkowska, Elżbieta Płuciennik, Zbigniew Pasieka, Lin-Yong Zhao, Adrianna Gielecińska, Mateusz Kciuk, Karol Kłosiński, Żaneta Kałuzińska-Kołat, Damian Kołat
Piotr Gromek, Zuzanna Senkowska, Elżbieta Płuciennik, Żaneta Kałuzińska-Kołat, Damian Kołat, Department of Functional Genomics, Medical University of Lodz, Lodz 90-752, Lodzkie, Poland
Zbigniew Pasieka, Karol Kłosiński, Żaneta Kałuzińska-Kołat, Damian Kołat, Department of Biomedicine and Experimental Surgery, Medical University of Lodz, Lodz 90-136, Lodzkie, Poland
Lin-Yong Zhao, Department of General Surgery & Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
Lin-Yong Zhao, Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
Adrianna Gielecińska, Mateusz Kciuk, Department of Molecular Biotechnology and Genetics, University of Lodz, Lodz 90-237, Lodzkie, Poland
Adrianna Gielecińska, Doctoral School of Exact and Natural Sciences, University of Lodz, Lodz 90-237, Lodzkie, Poland
Author contributions: Gromek P, Senkowska Z, and Kołat D conceptualized the article; Kołat D supervised the article; Gromek P, Senkowska Z, Płuciennik E, Pasieka Z, Zhao LY, Gielecińska A, Kciuk M, Kłosiński K, Kałuzińska-Kołat Ż, and Kołat D reviewed the literature; Gromek P, Senkowska Z, and Kołat D wrote the original draft; Gromek P, Senkowska Z, Płuciennik E, Pasieka Z, Zhao LY, Gielecińska A, Kciuk M, Kłosiński K, Kałuzińska-Kołat Ż, and Kołat D reviewed and edited article; All authors have read and agreed to the published version of the manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
https://creativecommons.org/Licenses/by-nc/4.0/ Corresponding author: Damian Kołat, BSc, MSc, Research Assistant, Teaching Assistant, Department of Functional Genomics, Medical University of Lodz, Żeligowskiego 7/9, Lodz 90-752, Lodzkie, Poland.
damian.kolat@umed.lodz.pl
Received: February 14, 2024
Revised: April 15, 2024
Accepted: April 28, 2024
Published online: June 20, 2024
Processing time: 120 Days and 11.5 Hours
In accordance with the World Health Organization data, cancer remains at the forefront of fatal diseases. An upward trend in cancer incidence and mortality has been observed globally, emphasizing that efforts in developing detection and treatment methods should continue. The diagnostic path typically begins with learning the medical history of a patient; this is followed by basic blood tests and imaging tests to indicate where cancer may be located to schedule a needle biopsy. Prompt initiation of diagnosis is crucial since delayed cancer detection entails higher costs of treatment and hospitalization. Thus, there is a need for novel cancer detection methods such as liquid biopsy, elastography, synthetic biosensors, fluorescence imaging, and reflectance confocal microscopy. Conventional therapeutic methods, although still common in clinical practice, pose many limitations and are unsatisfactory. Nowadays, there is a dynamic advancement of clinical research and the development of more precise and effective methods such as oncolytic virotherapy, exosome-based therapy, nanotechnology, dendritic cells, chimeric antigen receptors, immune checkpoint inhibitors, natural product-based therapy, tumor-treating fields, and photodynamic therapy. The present paper compares available data on conventional and modern methods of cancer detection and therapy to facilitate an understanding of this rapidly advancing field and its future directions. As evidenced, modern methods are not without drawbacks; there is still a need to develop new detection strategies and therapeutic approaches to improve sensitivity, specificity, safety, and efficacy. Nevertheless, an appropriate route has been taken, as confirmed by the approval of some modern methods by the Food and Drug Administration.
Core Tip: Cancer remains at the forefront of fatal diseases, with an upward trend in incidence and mortality. Conventional methods have many limitations, necessitating the development of novel diagnostic and therapeutic approaches. The present paper reviews conventional and modern methods of cancer detection and therapy to facilitate an understanding of the rapidly advancing field and its future directions. Modern methods are not without drawbacks; there is still a need for new strategies to improve sensitivity, specificity, safety, and efficacy. Nevertheless, some novel techniques have been approved for use in clinical settings, certifying that an appropriate route was taken.